Page 2 - Frederic Baudry News Today

03.09.21 -- Incorporating Excipients Into QbD Studies For Drug Development -- An Introduction     Orphan drugs are notorious for their high costs and risk factors, which are attributed to smaller patient pools and higher development and launch costs.   Attend this webinar to learn more about key trends that are causing the rise of orphan drug indications, fast-tracking early development phases that will lead to commercial success, and more!     By Brian Ca...

By Reuters Staff Slideshow ( 2 images ) SYDNEY (Reuters) - Qantas Airways Ltd and BP PLC on Thursday announced a strategic partnership to reduce carbon emissions in the aviation sector in Australia as part of their goals to become carbon neutral companies by 2050. The agreement, along with Air New Zealand Ltd on Thursday backing the New Zealand government’s decision to implement a biofuels mandate to cut carbon emissions in the transport sector, is a sign that the coronavirus pandemic has not...

01.21.21 -- Using Production And Postmarket Data To Validate FMEA Assumptions   Acepodias Dr. Sony Hsiao, CEO, and Dr. Mark Gilbert, SVP of R&D, join Business of Biotech for a discussion on the companys approach to dramatically reducing the cost of cell therapy development, manufacturing, and administration via its oNK, CAR, and ACC candidates. Listen now and subscribe so you never miss an episode. Featured Editorial By Mark Durivage, Quality Systems Complian...

Newsletter | December 22, 2020 12.22.20 -- The 12 Months Of Quality: Tips For Building A Voluntary QA Culture In A 2021 COVID World   On The Business Of Biotech, AGTC CEO Sue Washer gives a behind-the-scenes look at the creative measures her company took to serve a geographically dispersed clinical patient population and ensure her company met clinical milestones during the COVID-19 pandemic. Listen now and subscribe so you never miss...